Te Pātaka Whaioranga – Pharmac has announced the funding of two new medicines - pembrolizumab (branded as Keytruda) and atezolizumab (branded as Tecentriq)for people with locally advanced and metastatic non-small cell lung cancer who meet certain eligibility criteria.
Te Pātaka Whaioranga – Pharmac is widening access to the annual funded flu vaccine to tamariki aged 6 months to 12 years and will again offer it to Māori and Pacific peoples who are 55 to 64 years of age for the 2023 flu season
Te Pātaka Whaioranga – Pharmac is creating visibility of what medicines are being considered that could impact the rare disorders community by sharing the agenda items for the upcoming Rare Disorders Advisory Committee meeting
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management